← Eichor
Condition: Colon Cancer Stage Iii Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Colon Cancer Stage Iii

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Pa
Phase 3 · 60 location(s) · ECOG-ACRIN Cancer Research Group · NCT05863195Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Phase 1/Phase 2 · 27 location(s) · Institut de Recherches Internationales Servier · NCT05786924Circulating Tumor DNA Methylation Guided Postoperative Adjuvant Chemotherapy for High-risk Stage II/III Colorectal Cance
Phase 3 · 1 location(s) · Fudan University · NCT05954078Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cem
Phase 1/Phase 2 · 6 location(s) · National Cancer Institute (NCI) · NCT07147231MRD-guided Deferred Adjuvant Therapy in Resectable Early-stage Colon Cancer
NA · 1 location(s) · Sun Yat-sen University · NCT06204484Personalising and Refining Neo-adjuvant Chemotherapy in Locally Advanced but Resecable Colon Cancer in the Elderly of 70
Phase 3 · 1 location(s) · Centre Hospitalier Universitaire Dijon · NCT06293625Family Communications After Genetic Testing
NA · 276 location(s) · Alliance for Clinical Trials in Oncology · NCT07143487Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer
Phase 2/Phase 3 · 16 location(s) · Centre Hospitalier Universitaire de Besancon · NCT05462613The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors
Phase N/A · 1 location(s) · Case Comprehensive Cancer Center · NCT04624555Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cance
NA · 13 location(s) · City of Hope Medical Center · NCT07125729CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With
Phase 2 · 1 location(s) · Northwestern University · NCT05733000Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or G
Phase 1 · 1 location(s) · Roswell Park Cancer Institute · NCT04511039PACE: PD-1 Antibody For dMMR/MSI-H Stage III Colorectal Cancer
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT05236972Platform Study of Circulating Tumor DNA Directed Adjuvant Chemotherapy in Colon Cancer (KCSG CO22-12)
Phase 3 · 3 location(s) · Seoul National University Hospital · NCT05534087Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT05194878Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer
Phase 2/Phase 3 · 1 location(s) · Chungnam National University Hospital · NCT05179889Clinical Research on the Treatment Model of Ambulatory Surgery for Colorectal Cancer
NA · 1 location(s) · First Hospital of China Medical University · NCT06637215A Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal Cancer
Phase 3 · 6 location(s) · Jiangsu Simcere Pharmaceutical Co., Ltd. · NCT07361003NEOadjuvant PembRolizumab In Stratified Medicine - ColoRectal Cancer
Phase 2 · 6 location(s) · University College, London · NCT05197322A Study of Neoadjuvant QL1706 in Participants With Untreated dMMR/MSI-H Resectable Colon Cancer
Phase 3 · 1 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT06686576Early Detection of Advanced Adenomas and Colorectal Cancer
Phase N/A · 6 location(s) · City of Hope Medical Center · NCT06342440ctDNA-guided Selection of Adjuvant Chemotherapy Regimens for Elderly Colon Cancer Patients After Surgery: A Single-cente
Phase 3 · 1 location(s) · Zhejiang Cancer Hospital · NCT06609551Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial
Phase 3 · 1 location(s) · Roswell Park Cancer Institute · NCT06563388Phase II Study of Neoadjuvant Dostarlimab in Patients With Untreated T3-4N0-2 or Stage III pMMR/MSS Resectable Colon Can
Phase 2 · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT06830239Virtual Rehabilitation for Cancer Survivors
NA · 1 location(s) · University Health Network, Toronto · NCT05898789Early Onset Colorectal Cancer Detection
Phase N/A · 13 location(s) · City of Hope Medical Center · NCT06342401Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer
Phase N/A · 1 location(s) · Xijing Hospital · NCT06613165The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treat
NA · 2 location(s) · Dana-Farber Cancer Institute · NCT06565052Intraoperative Indocyanine Green Fluorescence Angiography in Colorectal Surgery to Prevent Anastomotic Leakage
Phase 3 · 32 location(s) · Centre Hospitalier Universitaire de Besancon · NCT05168839Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA
Phase 3 · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT05797077
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.